Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-26

Clinical Trial Update: HIV Vaccine Study in HIV Positive Patients [Phase 1]

View source ↗

Summary

A Phase 1 HIV vaccine trial in HIV-positive participants has completed, sponsored by PepTcell Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HIV vaccine candidate (investigational) (HIV vaccine)

Snippet

Sponsor: PepTcell Limited | Conditions: HIV Infections | Phase 1 | Status: COMPLETED